Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

15.15
-0.0400-0.26%
Post-market: 15.190.0400+0.26%17:46 EDT
Volume:2.29M
Turnover:35.03M
Market Cap:2.42B
PE:-46.56
High:15.59
Open:15.19
Low:15.10
Close:15.19
52wk High:20.76
52wk Low:9.07
Shares:159.76M
Float Shares:117.37M
Volume Ratio:1.51
T/O Rate:1.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3254
EPS(LYR):-0.3922
ROE:-23.95%
ROA:-5.74%
PB:11.19
PE(LYR):-38.63

Loading ...

Adaptive Biotech says clonoSEQ MRD test features in 33 ASCO, EHA presentations

Reuters
·
Yesterday

Adaptive Biotechnologies Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
May 13

Morgan Stanley Lowers Price Target on Adaptive Biotechnologies to $18 From $21, Keeps Equalweight Rating

MT Newswires Live
·
May 12

A Look At Adaptive Biotechnologies (ADPT) Valuation After Strong Q1 MRD Growth And Raised Full Year Guidance

Simply Wall St.
·
May 10

Stock Track | Adaptive Biotechnologies Soars 8.85% in Pre-market on Strong Q1 Earnings Beat and Analyst Support

Stock Track
·
May 06

Adaptive Biotechnologies Price Target Maintained With a $22.00/Share by BTIG

Dow Jones
·
May 06

J.P. Morgan Reaffirms Their Buy Rating on Adaptive Biotechnologies (ADPT)

TIPRANKS
·
May 06

Stock Track | Adaptive Biotechnologies Soars 5.30% in Night Session on Strong Q1 Earnings Beat

Stock Track
·
May 06

Adaptive Biotechnologies Q1 revenue beats estimates on MRD growth

Reuters
·
May 06

Stock Track | Adaptive Biotechnologies Soars 16.11% After-Hours on Strong Q1 Earnings Beat

Stock Track
·
May 06

Adaptive Biotechnologies Q1 EPS $(0.13) Beats $(0.17) Estimate, Sales $70.874M Beat $60.850M Estimate

Benzinga
·
May 06

BRIEF-Adaptive Biotechnologies Q1 EPS USD -0.13

Reuters
·
May 06

Adaptive Biotechnologies Q1 Net Income USD -20.015 Million

THOMSON REUTERS
·
May 06

Adaptive Biotechnologies Corp - Sees FY2026 Operating Expenses $350 Mln-$360 Mln

THOMSON REUTERS
·
May 06

Adaptive Biotechnologies Q1 Adjusted Ebitda USD -2.5 Million VS. Ibes Estimate USD -6.55 Million

THOMSON REUTERS
·
May 06

Stock Track | Adaptive Biotechnologies Plummets 5.03% Intraday Ahead of Q1 Earnings Report

Stock Track
·
May 05

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 04

Assessing Adaptive Biotechnologies (ADPT) Valuation After Recent Share Price Weakness

Simply Wall St.
·
May 03

Adaptive Biotech President, COO Julie Rubinstein sells 19,037 shares for $270,197.51

Reuters
·
Apr 30

Earning Preview: Adaptive Biotechnologies Corp Q1 revenue is expected to increase by 42.58%, and institutional views are cautiously bullish

Earnings Agent
·
Apr 29